Drug intelligence / Profile preview

dexamethasone + triamcinolone acetonide

Development stage
Unknown
Lead developer
Harrow
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intraarticular, Intramuscular, Intranasal, Intravenous, Intravitreal, Ophthalmic, Oral, Topical
01

Overview

This is a combination of two synthetic corticosteroids, dexamethasone and triamcinolone acetonide. Both are potent anti-inflammatory and immunosuppressive agents used to treat a wide range of inflammatory, allergic, autoimmune, and some neoplastic conditions. Dexamethasone is known for its high glucocorticoid potency and long duration of action. Triamcinolone acetonide is a more potent derivative of triamcinolone with enhanced topical activity and reduced mineralocorticoid effect; it is commonly used in injectable, topical, nasal spray, or intravitreal forms for various indications including joint inflammation, skin disorders, allergic rhinitis, macular edema associated with uveitis or diabetic macular edema (DME), among others[3][6][8]. The combination may be considered in clinical scenarios where additive or synergistic anti-inflammatory effects are desired. However, studies suggest that combining these corticosteroids (or either one) with other agents such as anti-VEGF drugs does not necessarily improve efficacy but increases the risk of side effects like elevated intraocular pressure[1].

02

Targets

MR (Mineralocorticoid receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on dexamethasone + triamcinolone acetonide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + triamcinolone acetonide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call